Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere
Hosted by bioaccess® CEO, Julio G. Martinez-Clark, the Global Trial Accelerators™ podcast delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia.
What You’ll Learn:
- Speed Secrets: How to secure ethics approval in 4–6 weeks (vs. 6+ months in US/EU) using harmonized pathways like MINSA (Panama), ALIMS (Serbia), and Australia’s CTN.
- Cost-to-Speed Hacks: Operational strategies to reduce trial budgets by 30% while maintaining FDA/EMA compliance.
- Global Patient Access: Leverage treatment-naive populations in cardiology, rare diseases, and advanced therapies across 50+ pre-vetted sites.
Why Listen?
- Actionable Playbooks: Reverse-engineer success stories from startups that enrolled cohorts 50% faster and secured Series B funding 12–18 months early.
- Regulatory Intel: Stay ahead of shifting LATAM, Balkans, and APAC guidelines with on-the-ground experts.
- Future-Proof Insights: Explore decentralized trials, AI-driven recruitment, and post-trial commercialization in $1B+ markets.
“bioaccess®’s Serbia site activated in 8 weeks-9 months faster than our EU delay.
This podcast is why we partnered with them.”
– Digital Health Startup CEO
New episodes drop weekly. Subscribe to unlock your shortcut to global trial velocity.
Brought to you by bioaccess® – Turning “anywhere” into accelerated FDA/EMA submissions since 2010.
Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere
Matt DeNardo, Chief Product Officer at Axoft
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
In this episode, we’re joined by Matt DeNardo, a biomedical engineer and product development leader with a passion for transforming complex clinical challenges into innovative medical technologies.
Matt shares how his approach combines the rigor of systems engineering with the creativity of design thinking, enabling teams to translate unmet clinical needs into clear product strategies and successful execution. From aligning user needs and regulatory considerations to leading cross-functional teams through every stage of development, he offers valuable insights into what it takes to bring meaningful healthcare innovations to market.
Holding an M.S. in Biomedical Engineering from Northwestern University and a B.S.E. in Bioengineering from the University of Pennsylvania, Matt has spent his career at the forefront of medical technology, continuously exploring emerging technologies that can improve patient outcomes and shape the future of healthcare.